# The Impact of Rituximab in Patients With Primary Breast Diffuse Large B Cell Lymphoma (DLBCL)

> **NCT01266668** · — · COMPLETED · sponsor: **Chonbuk National University Hospital** · enrollment: 100 (actual)

## Conditions studied

- Lymphoma, Large B-Cell, Diffuse

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01266668
- **Lead sponsor:** Chonbuk National University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2011-05
- **Final completion:** 2011-06
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2011-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01266668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01266668, "The Impact of Rituximab in Patients With Primary Breast Diffuse Large B Cell Lymphoma (DLBCL)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01266668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*